Screening for Breast Cancer¶
Siu, A. L., & Force, o. b. o. t. U. S. P. S. T. (2016). Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164(4), 279-296.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Asymmetric Screening
- In medical screening it is mammography, PSA testing, lateral-flow tests, and prenatal screening, all designed for high sensitivity at the cost of specificity, with downstream diagnostic follow-up resolving the false positives.
This sourceDocuments screening mammography deliberately tuned for high sensitivity over specificity, with diagnostic workup resolving the false positives the screen admits.
- In medical screening it is mammography, PSA testing, lateral-flow tests, and prenatal screening, all designed for high sensitivity at the cost of specificity, with downstream diagnostic follow-up resolving the false positives.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:8bf0870db9ae · see in the full table